MIR200CHG

Across TCGA pan-cancer cohorts, MIR200CHG RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MIR200CHG data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR200CHG RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR200CHG expression acts as an unfavorable survival marker, although some lineages such as BLCA and UCS show a favorable association.

BLCA, SKCM, and KIRP are the cancer types where MIR200CHG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Quartile	All	0.614	0.434	.001	68	view →
SKCM	OS	Tertile	All	0.694	0.812	<.001	67	view →
KIRP	DFS	Quartile	III,IV	0.333	0.699	.002	34	view →
ACC	DFS	Tertile	IV	0.010	0.383	<.001	27	view →
UCS	DFS	Tertile	IV	0.885	0.250	.024	24	view →
UVM	DFS	Tertile	All	0.223	0.783	.004	21	view →
KIRC	DFS	Tertile	III,IV	0.374	0.515	.021	21	view →
STAD	DFS	Quartile	II,III,IV	0.528	0.368	.021	19	view →
THYM	DFS	Tertile	II,III,IV	0.461	0.918	.021	18	view →
GBM	DFS	Tertile	All	0.099	0.295	.029	18	view →
TGCT	DFS	Tertile	All	0.561	0.916	<.001	18	view →
COAD	OS	Tertile	III,IV	0.729	0.894	.014	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MIR200CHG–BLCA (DFS)

Open the BLCA breakdown →